Targets Moving the Wrong Way
A year ago, Elliott took a stake of roughly $4 billion in PepsiCo. After talks with Elliott, the company set a target in December to lift its core operating margin by 100 basis points over three years. Yet despite record productivity savings and price cuts of up to 15% on products such as Lay’s and Doritos in February, its first-half margin fell 15 basis points to 16.3% of revenue.
They have not identified a focused path to recovery in the face of the ‘changes’ that they’ve made. They were simply too late, and now they have the threat of GLP-1s.
Stephanie Link, chief investment strategist at PepsiCo investor Hightower Advisors, argues the company was slow to adapt. Elliott and PepsiCo did not respond to requests for comment.
The Weight-Loss Drug Threat
GLP-1 weight-loss drugs have forced food producers from Kraft Heinz to Conagra Brands to launch healthier products. PepsiCo has also embraced the trend, with launches including Doritos Protein, SunChips Fiber and Good Warrior beef sticks.















